Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapy-Reference-Cited by-同舟云学术

Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapy

Published:2016-01-24 Issue:7 Volume:18 Page:991-1001
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro Oncol

Author:

Saran Frank,Chinot Olivier L.,Henriksson Roger,Mason Warren,Wick Wolfgang,Cloughesy Timothy,Dhar Sunita,Pozzi Emanuela,Garcia Josep,Nishikawa Ryo

Funder

F. Hoffmann-La Roche Ltd

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/18/7/991/17430544/nov300.pdf

Reference19 articles.

1. Avastin Periodic Safety Update Report (PSUR) (Data on file).

2. Avastin® SPC. Available at http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000582/WC500029271.pdf . Accessed April 16, 2015.

3. Reoperation for Recurrent High-Grade Glioma

4. Multiple resections for patients with glioblastoma: prolonging survival

5. The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is add-on Bevacizumab therapy to Temozolomide and radiotherapy associated with clinical utility for newly diagnosed Glioblastoma? A systematic review and meta-analysis;Neurosurgical Review;2024-08-20

2. Importance of Autophagy Regulation in Glioblastoma with Temozolomide Resistance;Cells;2024-08-11

3. Clinical features and treatment of apoplectic intratumoral hemorrhage of glioma;BMC Neurology;2024-07-24

4. The efficacy and adverse events of bevacizumab combined with temozolomide in the treatment of glioma: a systemic review and meta-analysis of randomized controlled trials;Frontiers in Medicine;2024-07-02

5. Design, synthesis and biological evaluation of Nrf2 modulators for the treatment of glioblastoma multiforme;Bioorganic & Medicinal Chemistry;2024-04